Dr. Damien Kee

Claim this profile

Austin Health

Studies Melanoma
Studies Cancer
3 reported clinical trials
6 drugs studied

Area of expertise

1Melanoma
Damien Kee has run 2 trials for Melanoma. Some of their research focus areas include:
Stage IV
BRAF positive
Stage II
2Cancer
Damien Kee has run 1 trial for Cancer. Some of their research focus areas include:
Stage IV

Clinical Trials Damien Kee is currently running

Image of trial facility.

APG-115 + Pembrolizumab

for Skin Cancer

This study aims to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of APG-115, an MDM2 inhibitor, either alone or in combination with pembrolizumab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with metastatic melanomas or advanced solid tumors. Our hypothesis is that restoration of the immune response concomitant to inhibition of the MDM2 pathway (which restores p53 functions) may promote cancer cell death, leading to effective anticancer therapy.
Recruiting1 award Phase 1 & 213 criteria

More about Damien Kee

Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Damien Kee has experience with
  • BMS-986249
  • Nivolumab
  • APG-115
  • Pembrolizumab
  • Encorafenib
  • Binimetinib
Breakdown of trials Damien Kee has run
Melanoma
Cancer
Peripheral Nerve Sheath Tumor
Neurofibrosarcoma
Head and Neck Cancers

Other Doctors you might be interested in

Andrew J WeickhardtAustin Health
Shane White, MDAustin Health
Lawrence CherAustin Hospital

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Damien Kee specialize in?
Damien Kee focuses on Melanoma and Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are BRAF positive.
Is Damien Kee currently recruiting for clinical trials?
Yes, Damien Kee is currently recruiting for 1 clinical trial in Heidelberg Victoria. If you're interested in participating, you should apply.
Are there any treatments that Damien Kee has studied deeply?
Yes, Damien Kee has studied treatments such as BMS-986249, Nivolumab, APG-115.
What is the best way to schedule an appointment with Damien Kee?
Apply for one of the trials that Damien Kee is conducting.
What is the office address of Damien Kee?
The office of Damien Kee is located at: Austin Health, Heidelberg, Victoria 3084 Australia. This is the address for their practice at the Austin Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top